<p>ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Sy
TitleCHFJPY H4 | Rising into 50% Fibo resistanceTypeBearish ReversalPreference:Price is rising towards the pivot point of 166.555 which is an overlap resistance that aligns with the 50.0% Fibonacci re
Leave a Comment